rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Nu Skin Enterprises, Inc.

NUS · NYSE

Health CareHealth Care DistributionNot moving yet

NUS stood above a rising 150-day average in 13 of the last 52 weekly readings, and has been out of that trend for the last 36 weeks. It is 10.0% below that average now. Health Care Distribution: 20% of its 10 stocks in an uptrend (−10 points in four weeks); Health Care: 25% (−11 points in four weeks).

Statistics

Rotation
Not moving yet
Weeks in an uptrend
out for 36
Industry in uptrend
20% -10 in 4 wk
Insider buys, 12 months
$53K
Insider sales, 12 months
$199K
Officials’ trades on record
0
Institutions holding
151 (-16)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 13 of 52 weeks.

17 Apr – 16 Oct
1%20%39%Apr 26Jun 26Jul 26Sep 26Oct 26

Health Care Distribution: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$377K$0Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months1
Sale orders, 12 months3
Buyers · sellers1 · 3
WhoDidSharesTraded
James M. WinettDirectorsold7,203at $5.622 Jun 2026filed 3 Jun 2026
Edwina D. WoodburyDirectorsold7,203at $5.701 Jun 2026filed 3 Jun 2026
Laura NathansonDirectorsold2,676at $6.7311 May 2026filed 12 May 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders151-16 on the quarter
New · exited23 · 38
Reported value$183.8M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
BlackRock, Inc.added · filed 7 Aug 20264,315,878$22.8M+24,615+0.6%
AMERICAN CENTURY COMPANIES INCadded · filed 12 Aug 20262,301,308$12.2M+280,106+13.9%
VANGUARD CAPITAL MANAGEMENT LLCreduced · filed 13 Aug 20262,049,641$10.8M-13,709−0.7%
DIMENSIONAL FUND ADVISORS LPadded · filed 11 Aug 20261,796,745$9.5M+61,563+3.5%
Prescott Group Capital Management, L.L.C.unchanged · filed 7 Aug 20261,794,608$9.5M00.0%
VANGUARD PORTFOLIO MANAGEMENT LLCadded · filed 13 Aug 20261,736,856$9.2M+27,303+1.6%
RENAISSANCE TECHNOLOGIES LLCreduced · filed 13 Aug 20261,607,692$8.5M-92,804−5.5%
CHARLES SCHWAB INVESTMENT MANAGEMENT INCreduced · filed 14 Aug 20261,452,937$7.7M-690,357−32.2%
Sixth Street Partners Management Company, L.P.new · filed 14 Aug 20261,452,937$7.7M+1,452,937
CastleKnight Management LPadded · filed 14 Aug 20261,389,633$7.3M+424,200+43.9%
31 Mar 2023 – 30 Jun 2026
152168184Mar 23Dec 23Dec 24Sep 25Jun 26

News

No headline names it lately.

Everyone who traded it

Edwina D. Woodbury Company insiderDirector · last 9 Sep 20260 · 6
James M. Winett Company insiderDirector · last 2 Jun 20260 · 1
Daniel W. Campbell Company insiderDirector · last 1 Jun 20264 · 5
Emma S. Battle Company insiderDirector · last 1 Jun 20260 · 4
Laura Nathanson Company insiderDirector · last 1 Jun 20260 · 3
Mark A. Zorko Company insiderDirector · last 1 Jun 20260 · 0
Pisano R. Thomas Company insiderDirector · last 1 Jun 20260 · 2
Chayce David Clark Company insiderEVP, COO and CLO · last 6 Mar 20260 · 1
James D. Thomas Company insiderChief Financial Officer · last 6 Mar 20260 · 3
Justin S. Keisel Company insiderEVP, President of Global Sales · last 6 Mar 20260 · 0
Ryan S. Napierski Company insiderPresident and CEO · last 6 Mar 20260 · 23
Steven Keith Hatchett Company insiderChief Product Officer · last 6 Mar 20262 · 2

Same industry

MCK McKessonAbove a falling average+19%
COSM Cosmos HealthAbove a falling average+17%
COR CencoraAbove a falling average+12%
HLF HerbalifeAbove a falling average+11%
ZSTK ZeroStackNot moving yet-11%
MEDS DataMeds AINot moving yet-31%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Profit per saleFY 2025 · to 31 Dec 202569.4%
Operating profit marginFY 2025 · to 31 Dec 20254.4%
Free cash flow marginFY 2025 · to 31 Dec 20253.1%
Return on capital employedFY 2025 · to 31 Dec 20255.8%
Cash conversionFY 2025 · to 31 Dec 202550.1%
Debt to equityFY 2025 · to 31 Dec 20250.28×
Research spendFY 2025 · to 31 Dec 20250.7%
Share count trendFY 2025 · to 31 Jan 2026-4.3%
Cash and equivalentsFY 2025 · to 31 Dec 2025$238.6M
Free cash flowFY 2025 · to 31 Dec 2025$46.0M

Analyst forecasts

No analyst forecasts yet.